Comment: Metastatic triple-negative breast cancer responds to immunotherapy

Comment: Metastatic triple-negative breast cancer responds to immunotherapy

Dr Louis Weiner, (Lombardi Comprehensive Cancer Center, Washington D.C, USA) comments on Prof Leisha Emen’s research for ecancertv at AACR 2015, He comments on how patients with triple-negative breast cancer have a worse prognosis than patients with other breast cancer subtypes, and in the United States, there is currently no targeted treatment available.

He also discusses high hopes for future treatments with an investigational targeted immunotherapy under development directed at metastatic triple-negative breast cancer.